Literature DB >> 2085596

Pathophysiology of ultrafiltration in peritoneal dialysis.

C Ronco1, M Feriani, S Chiaramonte, A Brendolan, L Bragantini, P Conz, R Dell'Aquila, M Milan, G La Greca.   

Abstract

Pathophysiology of peritoneal ultrafiltration is analyzed in the present study. Peritoneal equilibration test is the easiest procedure to study in detail the possible causes of failure to control the ultrafiltration rate in patients undergoing peritoneal dialysis. Membrane failure, reduction in peritoneal blood flow, excessive lymphatic reabsorption catheter malposition, and fluid sequestration are the most common causes of ultrafiltration loss. Pharmacologic manipulation of peritoneal membrane, correction of mechanical inconvenients, reduction in peritonitis rate and in the level of immunostimulation of the mesothelial macrophages, together with a careful policy in terms of glucose concentration in the dialysate and dwell times may contribute not only to treat different forms of ultrafiltration loss but also to prevent their incidence.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085596

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  3 in total

1.  TGF-β₁-siRNA delivery with nanoparticles inhibits peritoneal fibrosis.

Authors:  H Yoshizawa; Y Morishita; M Watanabe; K Ishibashi; S Muto; E Kusano; D Nagata
Journal:  Gene Ther       Date:  2015-01-08       Impact factor: 5.250

Review 2.  Nano-sized carriers in gene therapy for peritoneal fibrosis in vivo.

Authors:  Yusuke Igarashi; Taro Hoshino; Susumu Ookawara; Kenichi Ishibashi; Yoshiyuki Morishita
Journal:  Nano Rev Exp       Date:  2017-06-15

3.  Peritoneal equilibration test in costa rica: discrepancies from other populations.

Authors:  Marta Avellan-Boza; Fabio Hernández; Allan Ramos-Esquivel
Journal:  Int J Nephrol       Date:  2014-01-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.